Fisetin
Fisetin · also known as Fisetin, Smoke tree (Cotinus coggygria) extract
Fisetin showed potential to clear senescent cells in cell studies and in some high-dose mouse models, and it can affect mTOR, autophagy and inflammation-related markers. There is no reliable evidence that typical supplement doses selectively clear senescent cells in humans.
Clinical uses and human evidence
Inflammation markers (such as CRP)
Fatigue and energy
Mechanisms of action
Apoptosis-driven clearance of senescent cells (senolytic activity)
Fisetin showed potential to clear senescent cells in some cell models and in high-dose mouse experiments, where markers of senescence fell in some fat tissues. Selective clearance of senescent cells in humans has not been confirmed. The animal doses were high and should not be extrapolated to typical supplement doses.
mTORC1 allosteric inhibition and macroautophagy induction
In some animal models, fisetin changed mTOR and autophagy-related markers, and the direction of the effect varied by model. In a few cell models, autophagy was actually suppressed. Effects on autophagic flux in humans, and whether any effect depends on SIRT1, have not been confirmed.
Inhibition of NF-κB / AP-1, the master switches of pro-inflammatory transcription
In some animal models of inflammation, fisetin can reduce p65 nuclear entry and DNA binding. A drop in pro-inflammatory SASP factors does not by itself prove that NF-κB was inhibited, and the effect on this pathway in humans after usual oral doses is not yet clear.